Irritable Bowel Syndrome

Top Story

Probiotic improves depression, quality of life in IBS

June 19, 2017

The probiotic Bifidobacterium longum improved depression and quality of life, but not anxiety, among individuals with irritable bowel syndrome.

“This study shows that consumption of a specific probiotic can improve both gut symptoms and psychological issues in [irritable bowel syndrome],” Premysl Bercik, MD, of McMaster University, Hamilton, Ontario, said in a press release. “This opens new avenues not only for the treatment of patients with functional bowel disorders but also for patients with primary psychiatric diseases.”

FDA News

FDA accepts application to add IBS-C indication for Trulance

June 7, 2017
The FDA has accepted Synergy Pharmaceuticals’ supplemental new drug application to add constipation-predominant irritable bowel syndrome as an indication for…

OrphoMed secures $39 million to develop IBS-D treatment

June 5, 2017
OrphoMed Inc. completed a $39 million Series A financing, the capital of which they will use to accelerate clinical development of its lead candidate, ORP-101, a…
Meeting NewsVideo

VIDEO: Expert discusses breath testing, microbiome link in IBS

May 26, 2017
CHICAGO — In this exclusive video from Digestive Disease Week, Mark Pimentel, MD, executive director of the Medically Associated Science and Technology program at…
CME Video

JAK Inhibitors

This activity is supported by an educational grant from Receptos.

Janus kinase (JAK) inhibitors have emerged as  novel, orally administered small molecule therapies for the
More »
GI Bookshelf

Chapter 26: Medical Management of Severe Ulcerative Colitis

From Ulcerative Colitis: The Complete Guide to Medical Management
More »
Featured
Digestive Disease Week

Digestive Disease Week

Video
Meeting News Coverage

VIDEO: Chey discusses benefits of tenapanor in IBS-C

October 20, 2016
More »
In the Journals

Probiotic improves depression, quality of life in IBS

June 19, 2017
The probiotic Bifidobacterium longum improved depression and quality of life, but not anxiety, among individuals with irritable bowel syndrome. …

FDA News

FDA accepts application to add IBS-C indication for Trulance

June 7, 2017
The FDA has accepted Synergy Pharmaceuticals’ supplemental new drug application to add constipation-predominant irritable bowel syndrome as an…

OrphoMed secures $39 million to develop IBS-D treatment

June 5, 2017
OrphoMed Inc. completed a $39 million Series A financing, the capital of which they will use to accelerate clinical development of its lead…

Meeting NewsVideo

VIDEO: Expert discusses breath testing, microbiome link in IBS

May 26, 2017
CHICAGO — In this exclusive video from Digestive Disease Week, Mark Pimentel, MD, executive director of the Medically Associated Science and…

IBgard reduces IBS symptoms within 24 hours

May 25, 2017
CHICAGO —IBgard showed significant efficacy in a combined group of patients with irritable bowel syndrome with both diarrhea and constipation…

Tenapanor improves symptoms in IBS-C

May 15, 2017
Tenapanor, an investigational, minimally systemic, small-molecule NHE3 inhibitor, was well tolerated and improved symptoms in patients with…

Meeting NewsVideo

VIDEO: Older age, more severe IBS linked to relapse after treatment with Xifaxan

May 12, 2017
CHICAGO — In this exclusive video from Digestive Disease Week, Mark Pimentel, MD, executive director of the Medically Associated Science and…

Meeting News

Trulance improves symptoms in patients with IBS-C

May 11, 2017
CHICAGO — Trulance safely and effectively improved symptoms in patients with constipation-predominant irritable bowel syndrome, according to…

Meeting News

Low FODMAPs diet safe, effective under guide of expert nutritionist

May 8, 2017
CHICAGO — Researchers found that while a low FODMAP diet is safe and effective in patients with irritable bowel syndrome, patients were often…

Meeting News

FMT improves symptoms, QOL in IBS patients

May 8, 2017
CHICAGO — Fecal microbiota transplantation improved symptoms and quality of life in patients with irritable bowel syndrome, according to the…

More Headlines »
Advertisement
Advertisement